According to a new market report published by Lucintel, the future of fillers in the global pharmaceutical market looks promising with opportunities in tablets, capsules, ointment, and other pharmaceutical market. Fillers in the global pharmaceutical market are expected to reach an estimated $2 billion by 2024 with a CAGR of 5.7% from 2019 to 2024. The major drivers for this market are increasing government spending on healthcare, disease prevalence, along with growing demand for generic medicines.
Browse 128 market data tables and 133 figures spread through 200 pages and in-depth TOC on “Fillers in the Global Pharmaceutical Market”
Free customization on reports https://www.lucintel.com/pharmaceutical-fillers-market.aspx
In this market, different types of filler in pharmaceutical such as lactose, sucrose, mannitol, dextrose, sorbitol, starch, cellulose, calcium phosphate, talc, calcium carbonate, and others are used as filler type. On the basis of comprehensive research, Lucintel forecasts that lactose will remain the largest segment over the forecast period due to its high compatibility with active pharmaceutical ingredients (APIs) and increasing demand for antacid tablets.
Within the filler in pharmaceutical market, fillers for tablets will remain the largest application and it is also expected to witness the highest growth over the forecast period supported by increasing healthcare expenditure and higher incidence of chronic diseases.
Download Free PDF Brochure @ https://www.lucintel.com/pharmaceutical-fillers-market.aspx#/
North America will remain the largest region due to higher healthcare expenditure, advanced healthcare facilities, and aging population. Asia Pacific is expected to witness the highest growth over the forecast period due to the increasing government spending on healthcare infrastructure and increasing penetration of health insurance policies.
Pre-Purchase Query @ https://www.lucintel.com/pharmaceutical-fillers-market.aspx#/
An emerging trend that has a direct impact on the dynamics of fillers in the global pharmaceutical industry includes the increasing use of lactose in nanotechnology based drug formulation. DFE Pharma, Merck Group, Rayonier Advanced Materials, Meggle Group, Lactose India Limited, Imerys, Omya, Mineral Technologies, and Cargill Sorbitol and others are among the major filler in pharmaceutical manufacturers.
Lucintel, a leading global strategic consulting and market research firm, has analyzed the fillers in the global pharmaceutical market by application, filler type, and region and has come up with a comprehensive research report entitled “Growth Opportunities in the Fillers in the Global Pharmaceutical Market 2019-2024: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy as it provides a comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the fillers in the global pharmaceutical market by application, filler type, and region as follows:
By Application [Volume (kt) and $M shipment analysis for 2013 – 2024]:
– Direct Compression
– Wet Granulation
– Dry Granulation
By Filler Type [Volume (kt) and $M shipment analysis for 2013 – 2024]:
- Calcium Phosphate
- Calcium Carbonate
By Region [Value ($ Billion) and Volume (Billion Square Feet) from 2013 to 2024]:
- North America
- Asia Pacific
- The Rest of the World
Download Free Sample Page @ https://www.lucintel.com/pharmaceutical-fillers-market.aspx#/
This 200-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/pharmaceutical-fillers-market.aspx or [email protected].
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers following 11 key questions:
Q.1 What are some of the most promising, high-growth opportunities for the fillers in the global pharmaceutical market by filler type (lactose, sucrose, mannitol, dextrose, sorbitol, starch, cellulose, calcium phosphate, talc, calcium carbonate, and others), application (tablet, capsule, and others), and by region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and reasons behind them?
Q.7 What are some changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this area and how big of a threat do they pose for loss of market share via product substitution?
Q.11 What M&A activity has occurred in the last 5 years?
Company Name: Lucintel
Contact Person: Tushita Roy
Email: Send Email
Address:Lucintel, 8951 Cypress Waters Blvd., Suite 160, Dallas
State: TX 75019
Country: United States